Autolus Therapeutics PLC (AUTL)
2.84
+0.04
(+1.43%)
USD |
NASDAQ |
Nov 21, 16:00
2.86
+0.02
(+0.70%)
After-Hours: 20:00
Autolus Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -522.1% |
| December 31, 2023 | |
| September 30, 2023 | -11.29K% |
| June 30, 2023 | |
| March 31, 2023 | -3.08K% |
| December 31, 2022 | -704.6% |
| September 30, 2022 | -1.81K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | -2.20K% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | -15.42K% |
| June 30, 2020 | |
| March 31, 2020 | -8.84K% |
| December 31, 2019 | -1.41K% |
| September 30, 2019 | |
| June 30, 2019 | -8.43K% |
| March 31, 2019 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-15.42K%
Minimum
Sep 2020
-522.1%
Maximum
Mar 2024
-5.03K%
Average
-2.20K%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -43.07% |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Bicycle Therapeutics PLC | -1.90K% |